Cancer Incidence and Mortality among Whites, New York City, 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 11807.8 | 524.4 | 4.3 | 12230.2 | 416.6 | 3.4 | 3908.6 | 178.6 | 2.5 | 4107.6 | 129.7 | 1.8 |
| Oral cavity and pharynx | 324.2 | 14.0 | 0.7 | 159.6 | 5.3 | 0.4 | 70.2 | 3.1 | 0.3 | 33.0 | 1.0 | 0.2 |
| Esophagus | 156.0 | 6.9 | 0.5 | 64.4 | 2.0 | 0.2 | 133.4 | 6.0 | 0.5 | 53.0 | 1.6 | 0.2 |
| Stomach | 294.0 | 13.3 | 0.7 | 222.4 | 7.1 | 0.4 | 146.4 | 6.7 | 0.5 | 111.0 | 3.4 | 0.3 |
| Colorectal | 1197.4 | 54.0 | 1.4 | 1226.8 | 39.0 | 1.0 | 413.2 | 19.1 | 0.8 | 443.6 | 13.3 | 0.6 |
| Colon excluding rectum | 831.4 | 37.8 | 1.2 | 920.6 | 28.9 | 0.9 | 353.2 | 16.4 | 0.8 | 383.8 | 11.4 | 0.5 |
| Rectum & rectosigmoid | 366.0 | 16.2 | 0.7 | 306.2 | 10.1 | 0.5 | 60.0 | 2.7 | 0.3 | 59.8 | 1.8 | 0.2 |
| Liver / intrahepatic bile duct | 337.2 | 14.5 | 0.7 | 138.8 | 4.6 | 0.4 | 217.6 | 9.5 | 0.6 | 113.0 | 3.6 | 0.3 |
| Pancreas | 349.2 | 15.7 | 0.7 | 372.2 | 11.5 | 0.5 | 274.4 | 12.5 | 0.7 | 304.0 | 9.3 | 0.5 |
| Larynx | 159.2 | 7.0 | 0.5 | 45.0 | 1.6 | 0.2 | 52.6 | 2.3 | 0.3 | 12.4 | 0.4 | 0.1 |
| Lung and bronchus | 1441.8 | 65.4 | 1.5 | 1364.4 | 44.7 | 1.1 | 993.4 | 45.4 | 1.3 | 857.0 | 27.2 | 0.8 |
| Melanoma of the skin | 437.6 | 19.2 | 0.8 | 382.8 | 13.4 | 0.6 | 59.8 | 2.7 | 0.3 | 42.0 | 1.4 | 0.2 |
| Female breast | 3303.0 | 116.9 | 1.8 | 680.6 | 22.0 | 0.8 | ||||||
| Cervix uteri | 222.4 | 8.3 | 0.5 | 67.8 | 2.4 | 0.3 | ||||||
| Corpus uterus and NOS | 829.6 | 28.5 | 0.9 | 142.8 | 4.6 | 0.3 | ||||||
| Ovary | 378.4 | 13.1 | 0.6 | 233.6 | 7.6 | 0.4 | ||||||
| Prostate | 3023.0 | 133.0 | 2.1 | 389.4 | 18.6 | 0.8 | ||||||
| Testis | 152.2 | 5.9 | 0.4 | 6.4 | 0.3 | 0.1 | ||||||
| Urinary bladder (incl. in situ) | 820.4 | 37.6 | 1.2 | 301.2 | 9.5 | 0.5 | 152.4 | 7.2 | 0.5 | 77.4 | 2.2 | 0.2 |
| Kidney and renal pelvis | 474.2 | 20.9 | 0.8 | 280.4 | 9.6 | 0.5 | 96.6 | 4.4 | 0.4 | 59.8 | 1.8 | 0.2 |
| Brain and other nervous system | 182.6 | 8.0 | 0.5 | 161.4 | 5.9 | 0.4 | 103.0 | 4.5 | 0.4 | 84.2 | 2.9 | 0.3 |
| Thyroid | 201.8 | 8.4 | 0.5 | 615.6 | 23.3 | 0.8 | 14.2 | 0.7 | 0.2 | 20.6 | 0.7 | 0.1 |
| Hodgkin lymphoma | 94.2 | 4.0 | 0.4 | 81.2 | 3.1 | 0.3 | 16.0 | 0.7 | 0.2 | 9.2 | 0.3 | 0.1 |
| Non-Hodgkin lymphomas | 590.6 | 26.1 | 0.9 | 538.0 | 18.0 | 0.7 | 179.2 | 8.1 | 0.5 | 155.4 | 4.8 | 0.3 |
| Multiple myeloma | 169.8 | 7.6 | 0.5 | 149.4 | 4.9 | 0.4 | 70.0 | 3.2 | 0.3 | 58.0 | 1.8 | 0.2 |
| Leukemias | 360.0 | 16.3 | 0.8 | 296.6 | 10.1 | 0.5 | 172.4 | 7.9 | 0.5 | 163.0 | 5.3 | 0.4 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
